1. Residential Area Life Expectancy: Association With Outcomes and Processes of Care for Patients With ESRD in the United States 
Jesse D. Schold, Stuart M. Flechner, Emilio D. Poggio, Joshua J. Augustine, David A. Goldfarb, John R. Sedor, Laura D. Buccini 
American Journal of Kidney Diseases 
Volume 72, Issue 1, Pages (July 2018)
DOI: /j.ajkd
Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions

2. Figure 1
Kaplan-Meier plots of outcomes following end-stage renal disease (ESRD) onset. (A) Dialysis mortality, (B) placement on the deceased donor waiting list. (C) living donor transplantation, (D) posttransplantation overall graft loss, and (E) posttransplantation mortality. Life expectancy quintiles for women defined as quintile 1 (Q1)=(71.6, 78.7), Q2=(78.8, 80.0), Q3=(80.1, 81.0), Q4=(81.1, 82.1), Q5=(82.2, 88.3), and for men Q1=(63.1, 73.6), Q2=(73.7, 75.2), Q3=(75.3, 76.4), Q4=(76.5, 77.7), Q5=(77.8, 85.3).
American Journal of Kidney Diseases  , 19-29DOI: ( /j.ajkd )
Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions

3. Figure 1
Kaplan-Meier plots of outcomes following end-stage renal disease (ESRD) onset. (A) Dialysis mortality, (B) placement on the deceased donor waiting list. (C) living donor transplantation, (D) posttransplantation overall graft loss, and (E) posttransplantation mortality. Life expectancy quintiles for women defined as quintile 1 (Q1)=(71.6, 78.7), Q2=(78.8, 80.0), Q3=(80.1, 81.0), Q4=(81.1, 82.1), Q5=(82.2, 88.3), and for men Q1=(63.1, 73.6), Q2=(73.7, 75.2), Q3=(75.3, 76.4), Q4=(76.5, 77.7), Q5=(77.8, 85.3).
American Journal of Kidney Diseases  , 19-29DOI: ( /j.ajkd )
Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions

4. Figure 2
Adjusted hazard ratios following end-stage renal disease onset by residential life expectancy. Life expectancy quintiles for women defined as quintile 1 (Q1)=(71.6, 78.7), Q2=(78.8, 80.0), Q3=(80.1, 81.0), Q4=(81.1, 82.1), Q5=(82.2, 88.3) and for men Q1=(63.1, 73.6), Q2=(73.7, 75.2), Q3=(75.3, 76.4), Q4=(76.5, 77.7), Q5=(77.8, 85.3).
American Journal of Kidney Diseases  , 19-29DOI: ( /j.ajkd )
Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions

5. Figure 3
Adjusted hazard ratios of mortality following end-stage renal disease onset by residential life expectancy. (A) Female and (B) male life expectancy.
American Journal of Kidney Diseases  , 19-29DOI: ( /j.ajkd )
Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions

6. Figure 4
Proportion of patients with end-stage renal disease (ESRD) from lower life expectancy residential communities by ESRD Network. Regions included in ESRD Networks: 1 (Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont), 2 (New York), 3 (New Jersey, Puerto Rico, Virgin Islands), 4 (Delaware, Pennsylvania), 5 (Virginia, West Virginia, Maryland, District of Columbia), 6 (Georgia, North Carolina, South Carolina), 7 (Florida), 8 (Alabama, Mississippi, Tennessee), 9 (Indiana, Kentucky, Ohio), 10 (Illinois), 11 (Minnesota, Michigan, North Dakota, South Dakota, Wisconsin), 12 (Iowa, Kansas, Missouri, Nebraska), 13 (Arkansas, Louisiana, Oklahoma), 14 (Texas), 15 (Arizona, Colorado, Nevada, New Mexico, Utah, Wyoming), 16 (Alaska, Idaho, Montana, Oregon, Washington), 17 (American Samoa, Guam, Mariana Islands, Hawaii, Northern California), and 18 (Southern California). Life expectancy quintiles for women defined as quintile 1 (Q1) = (71.6, 78.7) and Q2 = (78.8, 80.0) and for men Q1 = (63.1, 73.6) and Q2 = (73.7, 75.2).
American Journal of Kidney Diseases  , 19-29DOI: ( /j.ajkd )
Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions